Medical Weight Loss for Savannah, Georgia Residents

Savannah, Georgia residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Savannah through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Honest pricing for Savannah patients: compounded semaglutide starts at $166 per month ($499 for the 90-day program) and tirzepatide from $233 per month, billed separately. No distance surcharge for Georgia residents. Doctor review just $119 (medication separate).

Why Savannah Residents Choose New Hope Weight Loss

If past attempts left you frustrated, Savannah, the difference here is structure and honesty. There is a real physician, Dr. Anjmun Sharma, behind your plan, a transparent price you can see up front, and a program that meets you by telehealth instead of dragging you across Georgia for every visit. Compounded semaglutide and tirzepatide are not magic and they are not FDA-approved, but paired with steady medical guidance they give a lot of people a genuine path forward.

From our Costa Mesa, California practice, we provide Savannah with physician-supervised GLP-1 care entirely by telehealth. Treatment is prescribed only after Dr. Sharma's review, and medication ships discreetly to your door.

We treat Savannah patients the way we treat everyone, with one licensed physician overseeing your care and telehealth carrying that care across Georgia instead of asking you to drive to California. We care for patients throughout the Historic District, Ardsley Park, the Southside, and the greater coastal Georgia area. There is no distance surcharge for living outside Costa Mesa, and we accept HSA, FSA, Klarna, and Affirm to make starting easier across Georgia.

Wherever you are in Savannah or the wider Georgia area, the program reaches you the same way, with HSA, FSA, Klarna, and Affirm all accepted. Tirzepatide, which shares its active ingredient with Mounjaro and Zepbound, starts at $233 per month for Savannah patients and is billed apart from the $119 visit. New Hope Weight Loss reaches patients all across fast-growing Georgia by secure telehealth from our Costa Mesa, California clinic, with no local office and no need to travel.

GLP-1 Weight Loss Programs Available

Which GLP-1 program is right for you?

Our 90-Day Metabolic Reset runs on semaglutide, the same active ingredient as Wegovy and Ozempic. It starts at $166 a month, or $499 for 90 days, and branded-drug trials reported average loss near 15 to 17 percent. Because compounded semaglutide is not FDA-approved or brand-identical, results vary. Dr. Sharma guides every Savannah patient by telehealth.

And if you want more horsepower

Tirzepatide, from $233 a month, adds GIP to the usual GLP-1 action. In branded-drug trials, dose-qualified participants reached up to 22.5 percent loss, which is not the typical outcome. It shares its active ingredient with Mounjaro and Zepbound.

A $119 physician review starts the process. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Savannah

Think of it as four easy moments. You begin with an online intake quiz that asks about your weight, your health history, and what you want to achieve. Dr. Anjmun Sharma then reviews your answers and meets you by secure video, generally within 48 hours, to talk honestly about whether compounded semaglutide or tirzepatide could help you. If she prescribes one, a state-licensed 503(a) pharmacy fills it and ships it to your Savannah address in protective cold-pack packaging. Finally, your follow-up care is delivered by video, so people throughout can stay on plan without ever sitting in a waiting room.

Frequently Asked Questions, Savannah

I am searching for weight loss care near Savannah. Where are you?

We are based in Costa Mesa, California, where our only physical clinic operates. Patients in Savannah, Georgia connect with us by telehealth instead of visiting. Dr. Anjmun Sharma conducts a video consult to review your goals and confirm whether you qualify for a compounded GLP-1 medication program.

Do I need to be seen in person if I live in Savannah?

Not at all. The telehealth format covers Savannah patients from start to finish, so no clinic visit is ever required. You speak with Dr. Sharma by video, and once you are approved, compounded medication ships to Savannah in cold-pack packaging built to keep it cool and stable.

What are the program costs for Savannah patients?

The physician review is priced at $119. Compounded semaglutide is available from $166 a month or $499 for the 90-day plan, and tirzepatide from $233 a month. Medication is invoiced separately. Payment options include HSA, FSA, Klarna, and Affirm, and Savannah patients face no distance surcharge.

What areas of Savannah do you serve?

We serve patients from across Savannah by telehealth, including the Historic District, Ardsley Park, the Southside, and the greater coastal Georgia area.

How does telehealth treatment work for Savannah patients?

You complete the online medical intake, Dr. Sharma reviews your history by secure video, typically within 48 hours, and if you are a candidate and telehealth-eligible, compounded medication ships to your Savannah address. Follow-ups also happen by video.

Savannah Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Savannah, Georgia by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.